← Back to headlines
UBS and Bernstein Upgrade Pharma and Telecom Stocks
UBS has upgraded Jazz Pharmaceuticals to a "Buy" rating with a new $307 price target, signaling a potential turning point for the company. Separately, Bernstein lifted American Tower to "Outperform" with a $207 price target, suggesting it's a good time to invest in tower REITs.
19 May, 16:24 — 19 May, 16:24
Sources
Showing 1 of 1 sources
